Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / HOTH - Hoth Therapeutics nabs U.S. patent for targeted 13-Cis-RAMBA retinamides


HOTH - Hoth Therapeutics nabs U.S. patent for targeted 13-Cis-RAMBA retinamides

U.S. Patent and Trademark Office has granted Hoth Therapeutics ([[HOTH]] +3.3%) patent No. 10,793,525 related to 13-Cis-RAMBA retinamides optimized to target key signaling pathways implicated in a variety of cancers. The patent expires on October 5, 2036.The potential therapeutic utility of these novel RAMBAs was shown in tumor xenograft animal models for both breast and prostate cancer.

For further details see:

Hoth Therapeutics nabs U.S. patent for targeted 13-Cis-RAMBA retinamides
Stock Information

Company Name: Hoth Therapeutics Inc.
Stock Symbol: HOTH
Market: NASDAQ
Website: hoththerapeutics.com

Menu

HOTH HOTH Quote HOTH Short HOTH News HOTH Articles HOTH Message Board
Get HOTH Alerts

News, Short Squeeze, Breakout and More Instantly...